Dr. Gil Hoftman is an Assistant Professor at UCLA Psychiatry, an attending in the TMS clinic, a Child & Adolescent Psychiatrist, and the Center for the Assessment and Prevention of Psychosis Risk Syndromes Medical Co-Director.
Driven by a passion for developing innovative approaches to understand and treat psychosis risk states including plans to develop the use of TMS in this population, Dr. Hoftman remains deeply connected with his patients and their families. He is dedicated to educating the next generation of behavioral health professionals and is recognized as an esteemed lecturer on medications for treating psychosis risk and comorbidities. What sets Dr. Hoftman apart in his approach to patient care is his integration of holistic and compassionate personalized care with an appreciation for the significance of developmental and neurobiological principles while also acknowledging the impact of environmental and psychological factors on distressing symptoms and experiences. This comprehensive approach ensures that each patient receives tailored care that addresses their unique needs.
Dr. Hoftman’s laboratory works in the areas of genetic and clinical high risk for psychosis, schizophrenia, and neurodevelopment using imaging transcriptomics and molecular neuroscience, with the goal of connecting the molecular underpinnings of disruptions in neural circuitry in psychosis risk to in vivo human brain development. His research is or has been funded by the National Institute of Mental Health, Burroughs Wellcome Fund Career Award for Medical Scientists, Sorensen Foundation Award for Child & Adolescent Psychiatrists, Brain and Behavior Research Foundation NARSAD Karen Seykora Young Investigator Award, UCLA Friends of Semel Institute Award, and Della Martin Award.
Dr. Hoftman is dedicated to delivering evidence based TMS treatment for depression and numerous additional conditions offered in clinic, as well as its applications for psychosis and in children and adolescents.
Medical Board Certifications
General Adult Psychiatry, American Board of Psychiatry and Neurology, 2020
Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 2021
Fellowship
Child & Adolescent Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Hospital, 2019
Neurobehavioral Genetics, National Institute of Mental Health T32, UCLA, 2021
Residency
Adult Psychiatry, University of Pittsburgh Medical Center, Western Psychiatric Hospital and UCLA Resnick Neuropsychiatric Hospital, 2020
Degrees
PhD, Neuroscience, University of Pittsburgh/Carnegie Mellon University, 2013
MD, Medicine, University of Pittsburgh School of Medicine, 2014
